# Filing Detail

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-25-249346
Filing Date
2025-10-24
Accepted
2025-10-24 07:17:38
Documents
156
Period of Report
2025-06-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 20-F | d33851d20f.htm iXBRL | 20-F | 3818985
2 | EX-4.1 | d33851dex41.htm | EX-4.1 | 144557
3 | EX-12.1 | d33851dex121.htm | EX-12.1 | 10255
4 | EX-13.1 | d33851dex131.htm | EX-13.1 | 5122
5 | EX-15.1 | d33851dex151.htm | EX-15.1 | 1463
7 | GRAPHIC | g33851g1007175555631.jpg | GRAPHIC | 110281
| Complete submission text file | 0001193125-25-249346.txt |  | 17967466

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
6 | XBRL TAXONOMY EXTENSION SCHEMA | immp-20250630.xsd | EX-101.SCH | 2684924
158 | EXTRACTED XBRL INSTANCE DOCUMENT | d33851d20f_htm.xml | XML | 4228015

Mailing Address LEVEL 32, SUITE 32.07 AUSTRALIA SQUARE 264 GEORGE STREET SYDNEY, C3 NSW 2000
Business Address LEVEL 32, SUITE 32.07 AUSTRALIA SQUARE 264 GEORGE STREET SYDNEY, C3 NSW 2000 612 8315 7003
IMMUTEP Ltd (Filer) CIK: 0001506184 (see all company filings)

EIN.: 000000000 | State of Incorp.: C3 | Fiscal Year End: 0630
Type: 20-F | Act: 34 | File No.: 001-35428 | Film No.: 251414280
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)